1AI
ALGORAE PHARMACEUTICALS LIMITED
$0.0090
▼ -5.56%
Market cap
$18M
Turnover
$14,179
Last price
$0.0090
Day change
-5.56%
Announcements
15
Range, past year
Open 0.010 · Low 0.005 · Now 0.009 · High 0.024
Open 1AI in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
1AI momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
28/100
Wyckoff phase
Accumulation31d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
+0.0%
1 Year
-10.0%
RSI
49
Avg daily range
8.3%
ALGORAE PHARMACEUTICALS LIMITED scores 28 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 31 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -27.3%
- High volatility (ATR 8.3%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
1AI announcements
Recent price-sensitive releases.
- 2026-10-30 Quarterly Activities Report and Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
- 2026-10-19 Algorae executes Licence & Supply Agreement with Umedica Progress Report
- 2026-10-16 Peter Mac partners with Algorae on 3rd AI validation program Progress Report
- 2026-08-31 Appendix 4E and 2026 Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-31 Quarterly Activities Report/Appendix 4C Cashflow Statement Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-03 Peter Mac Testing Validates AlgoraeOS v2
- 2026-07-02 Updated - NSW Health Public Hospital Supply Contract
More Health Care stocks
Most traded in the same sector.